BrainCo Helps Amputee Showcase Technology at WAIC 2025
BOSTON, Sept. 8, 2025 /PRNewswire/ -- At the 2025 World Artificial Intelligence Conference (WAIC) in August 2025, Gu demonstrated the...
News
Compugen to Present Research at the Single Cell Genomics 2025 Conference
HOLON, ISRAEL, Sept. 8, 2025 /PRNewswire/ -- Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a...
Desert Oasis Healthcare’s Dr. Brian Hodgkins to Share Expertise at California Society of Health-System Pharmacists Seminar 2025
Sharing Over 30 Years of Pharmacy Leadership, Dr. Hodgkins Represents DOHC at CSHP Seminar CHULA VISTA, CA / ACCESS Newswire...
SOLSTICE HEALTH Ranks No. 1520 on the 2025 Inc. 5000 List of America’s Fastest-Growing Private Companies
With Three-Year Revenue Growth of 287% Percent, This Marks Solstice Health's 1st Time on the List OCONOMOWOC, WISCONSIN / ACCESS...
Medical Care Technologies Inc. (OTC PINK:MDCE) Slashes Outstanding Share Count by 680,000,000 Shares
MESA, ARIZONA / ACCESS Newswire / September 8, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) (the "Company" or "MDCE")...
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM
Long-Term Data Adds to the Growing Body of Evidence Supporting the Compelling Clinical Profile of Pombiliti® + Opfolda®PRINCETON, N.J., Sept....
MediciNova Provides Shareholder Update on Key Developments
LA JOLLA, Calif., Sept. 08, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market...
Journal of Healthcare Management Study Uncovers Critical Gaps in Hospital Employee Surveys Used to Assess Risk of Clinician Turnover, Unveiling Need for Atalan Platform
Data found 12 times higher risk of turnover among nonresponding clinicians, revealing how nonresponse bias distorts survey results and emphasizing...
Femasys Secures Regulatory Approval for FemBloc® Permanent Birth Control in New Zealand
Expands international footprint with entry into Asia-Pacific, building on recent CE Mark and UK approvalsATLANTA, Sept. 08, 2025 (GLOBE NEWSWIRE)...
New Omada Health Analysis Shows Long-Term Weight Maintenance Post-GLP-1 Discontinuation, Challenging Industry Assumptions
Analysis shows Omada members maintained weight, with minimal (0.8%) average weight change, one year after discontinuing GLP-1s for weight loss,1...
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Programme
Groundbreaking Programme Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions WeightWatchers Introduces Comprehensive Menopause Program with Queen Latifah...
Queen Latifah Named Spokeswoman as WeightWatchers Launches First Comprehensive Menopause Program
Groundbreaking Program Tackles Weight, Symptoms and Stigma, Redefining Menopause Care for Millions NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) --...
CASI Pharmaceuticals Announces Safety Monitoring Committee Recommendation to Escalate CID-103 Dose to Next Cohort in Phase 1 Immune Thrombocytopenia (ITP) Study
- CID-103 is a potential best-in-class, clinical stage anti-CD38 monoclonal antibody- Safety profile observed in first four dose cohorts supports...
Lifeward Achieves CE Mark Approval for the ReWalk 7 Personal Exoskeleton
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European UnionMARLBOROUGH, Mass. and YOKNEAM ILLIT,...
From Telehealth to Trust: Flash Survey of WHX Attendees on the Next Wave of Middle East Digital Health Startups
Independent Black Book Findings on Compliance, Consent, and Patient Engagement from WHX Dubai Attendees DUBAI, AE / ACCESS Newswire /...
Cannabix Technologies to Exhibit at National Safety Council (NSC) Safety Congress and Expo, Denver Colorado
VANCOUVER, British Columbia, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (Frankfurt: 8CT) (the...
CS Diagnostics Corp. Submits Patent Application For CS-Protect Hydrogel in the US Market
PARTNERING WITH PAUL & ALBRECHT PATENT LAWYERS CHEYENNE, WYOMING / ACCESS Newswire / September 8, 2025 / CS Diagnostics Corp....
Moleculin Doses First EU Patient in Phase 3 Pivotal MIRACLE Trial for Treatment of Acute Myeloid Leukemia
Spain site opens with two R/R AML subjects enrolled; One treated On track to recruit 45 subjects in 4Q25 for...
Medicus Pharma Ltd. Provides Update on United Arab Emirates (UAE) SKNJCT-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
CLEVELAND CLINIC ABU DHABI (CCAD) HAS COMMENCED RECRUITMENT IN THIS 36 PARTICIPANT STUDY PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / September...
Dentsply Sirona Retains Wellspect Healthcare as a Portfolio Business Following Comprehensive Review of Strategic Alternatives
Determined that Wellspect will Deliver Greater Financial and Strategic Benefits to Stockholders as Part of the CompanyCHARLOTTE, N.C., Sept. 08,...